SEC Form 4 · accession 0000059478-15-000080
ELI LILLY & Co · LLY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David A Ricks
Officer — SVP and Pres, Lilly Bio-Meds
Period of report
Feb 4, 2015
Accepted (ET)
Feb 6, 2015 · 10:06 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000059478
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Feb 4, 2015 | S | 3,147 | $69.99 | D | 60,138 | D | |
| Common Stock | holding | — | — | — | 3,662 | I | 401(k) |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 4, 2014.
- F2This transaction was executed in multiple trades at prices ranging from $69.80 to $70.25. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.